JP2003533170A

JP2003533170A - アデノ随伴ウイルスおよびその使用

アデノ随伴ウイルスおよびその使用

Info

Publication number: JP2003533170A
Authority: JP; Japan
Prior art keywords: dna; aav; recombinant; dna segment; dna molecule
Prior art date: 1999-10-07
Legal status : Pending

Application number

JP2001528616A

Other languages

English (en)

Japanese (ja)

Other versions

JP2003533170A5 (https=

Inventor

エンゲルハート，ジヨン・エフ

ドウアン，ドングシエング

ヤン，ジイング

Original Assignee

ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン

Priority date

1999-10-07

Filing date

2000-10-06

Publication date

2003-11-11

2000-10-06 Application filed by ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン filed Critical ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン

2003-11-11 Publication of JP2003533170A publication Critical patent/JP2003533170A/ja

2007-11-22 Publication of JP2003533170A5 publication Critical patent/JP2003533170A5/ja

Status Pending legal-status Critical Current

Links

241000702421 Dependoparvovirus Species 0.000 title claims abstract description 209
108020004414 DNA Proteins 0.000 claims abstract description 308
239000013598 vector Substances 0.000 claims abstract description 153
102000053602 DNA Human genes 0.000 claims abstract description 84
239000000203 mixture Substances 0.000 claims abstract description 60
210000004027 cell Anatomy 0.000 claims description 253
239000013612 plasmid Substances 0.000 claims description 169
108090000623 proteins and genes Proteins 0.000 claims description 100
238000000034 method Methods 0.000 claims description 76
108020004511 Recombinant DNA Proteins 0.000 claims description 61
230000010076 replication Effects 0.000 claims description 52
108700026244 Open Reading Frames Proteins 0.000 claims description 43
230000003612 virological effect Effects 0.000 claims description 36
239000003623 enhancer Substances 0.000 claims description 35
108091028043 Nucleic acid sequence Proteins 0.000 claims description 25
102000004169 proteins and genes Human genes 0.000 claims description 25
108090000765 processed proteins & peptides Proteins 0.000 claims description 15
108020005067 RNA Splice Sites Proteins 0.000 claims description 13
229920001184 polypeptide Polymers 0.000 claims description 13
102000004196 processed proteins & peptides Human genes 0.000 claims description 13
239000003981 vehicle Substances 0.000 claims description 11
239000013603 viral vector Substances 0.000 claims description 9
239000003937 drug carrier Substances 0.000 claims description 4
210000005260 human cell Anatomy 0.000 claims description 4
238000013160 medical therapy Methods 0.000 claims 2
208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 claims 1
108700029229 Transcriptional Regulatory Elements Proteins 0.000 claims 1
125000004122 cyclic group Chemical group 0.000 abstract description 169
230000002688 persistence Effects 0.000 abstract description 86
230000001965 increasing effect Effects 0.000 abstract description 77
239000000543 intermediate Substances 0.000 description 278
230000014509 gene expression Effects 0.000 description 159
239000005090 green fluorescent protein Substances 0.000 description 137
108010043121 Green Fluorescent Proteins Proteins 0.000 description 136
102000004144 Green Fluorescent Proteins Human genes 0.000 description 136
210000003205 muscle Anatomy 0.000 description 126
108700019146 Transgenes Proteins 0.000 description 124
208000015181 infectious disease Diseases 0.000 description 67
241000701161 unidentified adenovirus Species 0.000 description 59
230000001580 bacterial effect Effects 0.000 description 49
239000002245 particle Substances 0.000 description 49
241000700605 Viruses Species 0.000 description 48
230000015572 biosynthetic process Effects 0.000 description 45
108091028732 Concatemer Proteins 0.000 description 44
238000002105 Southern blotting Methods 0.000 description 44
239000000523 sample Substances 0.000 description 42
238000001890 transfection Methods 0.000 description 42
108060001084 Luciferase Proteins 0.000 description 41
230000010354 integration Effects 0.000 description 40
208000003322 Coinfection Diseases 0.000 description 37
239000012634 fragment Substances 0.000 description 37
239000005089 Luciferase Substances 0.000 description 36
238000001727 in vivo Methods 0.000 description 35
239000013608 rAAV vector Substances 0.000 description 35
238000010361 transduction Methods 0.000 description 33
150000007523 nucleic acids Chemical class 0.000 description 32
230000006798 recombination Effects 0.000 description 32
238000005215 recombination Methods 0.000 description 32
230000026683 transduction Effects 0.000 description 32
238000002474 experimental method Methods 0.000 description 31
102000039446 nucleic acids Human genes 0.000 description 30
108020004707 nucleic acids Proteins 0.000 description 30
239000003814 drug Substances 0.000 description 28
230000001404 mediated effect Effects 0.000 description 28
241000588724 Escherichia coli Species 0.000 description 27
230000000694 effects Effects 0.000 description 26
238000002360 preparation method Methods 0.000 description 25
229940124597 therapeutic agent Drugs 0.000 description 25
239000000178 monomer Substances 0.000 description 23
241000894006 Bacteria Species 0.000 description 21
230000029087 digestion Effects 0.000 description 21
238000009396 hybridization Methods 0.000 description 21
210000001519 tissue Anatomy 0.000 description 21
230000007246 mechanism Effects 0.000 description 20
108091008146 restriction endonucleases Proteins 0.000 description 20
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 19
238000010186 staining Methods 0.000 description 19
239000013607 AAV vector Substances 0.000 description 18
-1 DNA Chemical class 0.000 description 18
102000052510 DNA-Binding Proteins Human genes 0.000 description 18
101710096438 DNA-binding protein Proteins 0.000 description 18
102100020903 Ezrin Human genes 0.000 description 18
238000004458 analytical method Methods 0.000 description 17
238000009472 formulation Methods 0.000 description 17
238000012546 transfer Methods 0.000 description 17
108091032973 (ribonucleotides)n+m Proteins 0.000 description 16
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 16
238000003556 assay Methods 0.000 description 16
229920000642 polymer Polymers 0.000 description 16
239000000243 solution Substances 0.000 description 16
108700028146 Genetic Enhancer Elements Proteins 0.000 description 15
108700008625 Reporter Genes Proteins 0.000 description 15
230000004913 activation Effects 0.000 description 15
101100297347 Caenorhabditis elegans pgl-3 gene Proteins 0.000 description 14
239000004480 active ingredient Substances 0.000 description 14
229960000723 ampicillin Drugs 0.000 description 14
239000003795 chemical substances by application Substances 0.000 description 14
238000000338 in vitro Methods 0.000 description 14
241000699670 Mus sp. Species 0.000 description 13
210000002950 fibroblast Anatomy 0.000 description 13
239000010410 layer Substances 0.000 description 13
239000007788 liquid Substances 0.000 description 13
230000007774 longterm Effects 0.000 description 13
239000011159 matrix material Substances 0.000 description 13
108020004999 messenger RNA Proteins 0.000 description 13
230000008569 process Effects 0.000 description 13
239000013605 shuttle vector Substances 0.000 description 13
108091034117 Oligonucleotide Proteins 0.000 description 12
230000001413 cellular effect Effects 0.000 description 12
238000002955 isolation Methods 0.000 description 12
239000002502 liposome Substances 0.000 description 12
210000001087 myotubule Anatomy 0.000 description 12
201000003883 Cystic fibrosis Diseases 0.000 description 11
241000701022 Cytomegalovirus Species 0.000 description 11
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
239000000499 gel Substances 0.000 description 11
238000001415 gene therapy Methods 0.000 description 11
239000000843 powder Substances 0.000 description 11
230000001105 regulatory effect Effects 0.000 description 11
238000012163 sequencing technique Methods 0.000 description 11
230000009466 transformation Effects 0.000 description 11
108010031111 EBV-encoded nuclear antigen 1 Proteins 0.000 description 10
210000001552 airway epithelial cell Anatomy 0.000 description 10
238000006243 chemical reaction Methods 0.000 description 10
230000006870 function Effects 0.000 description 10
239000007924 injection Substances 0.000 description 10
238000002347 injection Methods 0.000 description 10
239000000047 product Substances 0.000 description 10
210000002345 respiratory system Anatomy 0.000 description 10
239000000126 substance Substances 0.000 description 10
238000013459 approach Methods 0.000 description 9
238000012761 co-transfection Methods 0.000 description 9
210000000287 oocyte Anatomy 0.000 description 9
230000002085 persistent effect Effects 0.000 description 9
239000013615 primer Substances 0.000 description 9
230000003362 replicative effect Effects 0.000 description 9
101150002621 EPO gene Proteins 0.000 description 8
241001465754 Metazoa Species 0.000 description 8
241000699666 Mus <mouse, genus> Species 0.000 description 8
238000003491 array Methods 0.000 description 8
230000010310 bacterial transformation Effects 0.000 description 8
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 8
239000013592 cell lysate Substances 0.000 description 8
238000011109 contamination Methods 0.000 description 8
238000012217 deletion Methods 0.000 description 8
230000037430 deletion Effects 0.000 description 8
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
238000011156 evaluation Methods 0.000 description 8
239000002773 nucleotide Substances 0.000 description 8
125000003729 nucleotide group Chemical group 0.000 description 8
239000002953 phosphate buffered saline Substances 0.000 description 8
238000012916 structural analysis Methods 0.000 description 8
238000012360 testing method Methods 0.000 description 8
108020004638 Circular DNA Proteins 0.000 description 7
108020005202 Viral DNA Proteins 0.000 description 7
239000002998 adhesive polymer Substances 0.000 description 7
230000001588 bifunctional effect Effects 0.000 description 7
229920001577 copolymer Polymers 0.000 description 7
239000006185 dispersion Substances 0.000 description 7
210000004072 lung Anatomy 0.000 description 7
230000035772 mutation Effects 0.000 description 7
210000004940 nucleus Anatomy 0.000 description 7
230000001566 pro-viral effect Effects 0.000 description 7
230000009467 reduction Effects 0.000 description 7
241000894007 species Species 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
241000269370 Xenopus <genus> Species 0.000 description 6
239000011543 agarose gel Substances 0.000 description 6
108010005774 beta-Galactosidase Proteins 0.000 description 6
229920002678 cellulose Polymers 0.000 description 6
238000000576 coating method Methods 0.000 description 6
239000002552 dosage form Substances 0.000 description 6
239000013613 expression plasmid Substances 0.000 description 6
230000001744 histochemical effect Effects 0.000 description 6
239000004615 ingredient Substances 0.000 description 6
230000002101 lytic effect Effects 0.000 description 6
239000003550 marker Substances 0.000 description 6
239000000463 material Substances 0.000 description 6
238000005259 measurement Methods 0.000 description 6
210000000056 organ Anatomy 0.000 description 6
229920001223 polyethylene glycol Polymers 0.000 description 6
230000001177 retroviral effect Effects 0.000 description 6
238000007363 ring formation reaction Methods 0.000 description 6
210000003491 skin Anatomy 0.000 description 6
239000007787 solid Substances 0.000 description 6
230000008685 targeting Effects 0.000 description 6
230000001225 therapeutic effect Effects 0.000 description 6
230000036962 time dependent Effects 0.000 description 6
238000011282 treatment Methods 0.000 description 6
102100026189 Beta-galactosidase Human genes 0.000 description 5
108091003079 Bovine Serum Albumin Proteins 0.000 description 5
101150029409 CFTR gene Proteins 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
102000018120 Recombinases Human genes 0.000 description 5
108010091086 Recombinases Proteins 0.000 description 5
108700005077 Viral Genes Proteins 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
230000027455 binding Effects 0.000 description 5
239000000969 carrier Substances 0.000 description 5
235000010980 cellulose Nutrition 0.000 description 5
239000001913 cellulose Substances 0.000 description 5
230000007547 defect Effects 0.000 description 5
238000011161 development Methods 0.000 description 5
239000003085 diluting agent Substances 0.000 description 5
210000000981 epithelium Anatomy 0.000 description 5
210000003527 eukaryotic cell Anatomy 0.000 description 5
239000013604 expression vector Substances 0.000 description 5
238000000799 fluorescence microscopy Methods 0.000 description 5
239000008273 gelatin Substances 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
238000001476 gene delivery Methods 0.000 description 5
230000006698 induction Effects 0.000 description 5
230000003993 interaction Effects 0.000 description 5
239000006166 lysate Substances 0.000 description 5
239000002609 medium Substances 0.000 description 5
238000000520 microinjection Methods 0.000 description 5
238000002156 mixing Methods 0.000 description 5
230000037361 pathway Effects 0.000 description 5
230000035945 sensitivity Effects 0.000 description 5
239000003826 tablet Substances 0.000 description 5
238000013518 transcription Methods 0.000 description 5
230000035897 transcription Effects 0.000 description 5
230000037317 transdermal delivery Effects 0.000 description 5
238000003146 transient transfection Methods 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
108020004774 Alkaline Phosphatase Proteins 0.000 description 4
102000002260 Alkaline Phosphatase Human genes 0.000 description 4
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
101150066002 GFP gene Proteins 0.000 description 4
108091027305 Heteroduplex Proteins 0.000 description 4
102100034343 Integrase Human genes 0.000 description 4
101710163270 Nuclease Proteins 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
238000012300 Sequence Analysis Methods 0.000 description 4
229920002472 Starch Polymers 0.000 description 4
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
239000000443 aerosol Substances 0.000 description 4
210000000349 chromosome Anatomy 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000011260 co-administration Methods 0.000 description 4
238000010276 construction Methods 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
230000000120 cytopathologic effect Effects 0.000 description 4
239000000539 dimer Substances 0.000 description 4
230000009977 dual effect Effects 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
238000009585 enzyme analysis Methods 0.000 description 4
239000000284 extract Substances 0.000 description 4
239000012894 fetal calf serum Substances 0.000 description 4
239000011888 foil Substances 0.000 description 4
235000011187 glycerol Nutrition 0.000 description 4
230000012010 growth Effects 0.000 description 4
238000012760 immunocytochemical staining Methods 0.000 description 4
238000010166 immunofluorescence Methods 0.000 description 4
238000001802 infusion Methods 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
238000007918 intramuscular administration Methods 0.000 description 4
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
238000013508 migration Methods 0.000 description 4
230000005012 migration Effects 0.000 description 4
238000002703 mutagenesis Methods 0.000 description 4
231100000350 mutagenesis Toxicity 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
239000000546 pharmaceutical excipient Substances 0.000 description 4
238000000053 physical method Methods 0.000 description 4
229920000058 polyacrylate Polymers 0.000 description 4
239000003755 preservative agent Substances 0.000 description 4
230000001681 protective effect Effects 0.000 description 4
239000002904 solvent Substances 0.000 description 4
239000007921 spray Substances 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
239000000725 suspension Substances 0.000 description 4
238000011200 topical administration Methods 0.000 description 4
230000002463 transducing effect Effects 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
239000003298 DNA probe Substances 0.000 description 3
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
108010061833 Integrases Proteins 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
101100273988 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) paa-3 gene Proteins 0.000 description 3
238000000636 Northern blotting Methods 0.000 description 3
101710087110 ORF6 protein Proteins 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
108091081021 Sense strand Proteins 0.000 description 3
108020004682 Single-Stranded DNA Proteins 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
206010042566 Superinfection Diseases 0.000 description 3
101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 description 3
239000002671 adjuvant Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
238000010170 biological method Methods 0.000 description 3
239000007894 caplet Substances 0.000 description 3
229910052799 carbon Inorganic materials 0.000 description 3
125000002091 cationic group Chemical group 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
101150028015 cft1 gene Proteins 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000003776 cleavage reaction Methods 0.000 description 3
230000004186 co-expression Effects 0.000 description 3
230000008045 co-localization Effects 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
239000006071 cream Substances 0.000 description 3
230000002950 deficient Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
239000002270 dispersing agent Substances 0.000 description 3
229940079593 drug Drugs 0.000 description 3
210000002257 embryonic structure Anatomy 0.000 description 3
108010048367 enhanced green fluorescent protein Proteins 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
238000005194 fractionation Methods 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
230000004807 localization Effects 0.000 description 3
230000005923 long-lasting effect Effects 0.000 description 3
239000006210 lotion Substances 0.000 description 3
238000003670 luciferase enzyme activity assay Methods 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
210000001161 mammalian embryo Anatomy 0.000 description 3
238000013507 mapping Methods 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
238000001000 micrograph Methods 0.000 description 3
230000037230 mobility Effects 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
239000008194 pharmaceutical composition Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004033 plastic Substances 0.000 description 3
230000008488 polyadenylation Effects 0.000 description 3
229920006254 polymer film Polymers 0.000 description 3
229920005862 polyol Polymers 0.000 description 3
150000003077 polyols Chemical class 0.000 description 3
229920001296 polysiloxane Polymers 0.000 description 3
230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 3
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 3
239000002243 precursor Substances 0.000 description 3
108091007054 readthrough proteins Proteins 0.000 description 3
230000007017 scission Effects 0.000 description 3
239000008107 starch Substances 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
239000000375 suspending agent Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
239000000454 talc Substances 0.000 description 3
235000012222 talc Nutrition 0.000 description 3
229910052623 talc Inorganic materials 0.000 description 3
239000002562 thickening agent Substances 0.000 description 3
230000032258 transport Effects 0.000 description 3
241001430294 unidentified retrovirus Species 0.000 description 3
235000015112 vegetable and seed oil Nutrition 0.000 description 3
239000008158 vegetable oil Substances 0.000 description 3
238000001262 western blot Methods 0.000 description 3
VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000271566 Aves Species 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
206010053138 Congenital aplastic anaemia Diseases 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
108090000204 Dipeptidase 1 Proteins 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000003951 Erythropoietin Human genes 0.000 description 2
108090000394 Erythropoietin Proteins 0.000 description 2
201000004939 Fanconi anemia Diseases 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
208000015872 Gaucher disease Diseases 0.000 description 2
208000031220 Hemophilia Diseases 0.000 description 2
208000009292 Hemophilia A Diseases 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
238000012404 In vitro experiment Methods 0.000 description 2
108091092195 Intron Proteins 0.000 description 2
FFOPEPMHKILNIT-UHFFFAOYSA-N Isopropyl butyrate Chemical compound CCCC(=O)OC(C)C FFOPEPMHKILNIT-UHFFFAOYSA-N 0.000 description 2
108010007622 LDL Lipoproteins Proteins 0.000 description 2
102000007330 LDL Lipoproteins Human genes 0.000 description 2
101710128836 Large T antigen Proteins 0.000 description 2
240000007472 Leucaena leucocephala Species 0.000 description 2
235000010643 Leucaena leucocephala Nutrition 0.000 description 2
229920000168 Microcrystalline cellulose Polymers 0.000 description 2
108091061960 Naked DNA Proteins 0.000 description 2
108091093105 Nuclear DNA Proteins 0.000 description 2
102000007999 Nuclear Proteins Human genes 0.000 description 2
108010089610 Nuclear Proteins Proteins 0.000 description 2
208000018737 Parkinson disease Diseases 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
241000125945 Protoparvovirus Species 0.000 description 2
108010052090 Renilla Luciferases Proteins 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
230000001594 aberrant effect Effects 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000009471 action Effects 0.000 description 2
230000003321 amplification Effects 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
102000006635 beta-lactamase Human genes 0.000 description 2
239000007975 buffered saline Substances 0.000 description 2
229910000019 calcium carbonate Inorganic materials 0.000 description 2
239000002775 capsule Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
239000013553 cell monolayer Substances 0.000 description 2
108091092356 cellular DNA Proteins 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
230000008859 change Effects 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
239000003086 colorant Substances 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
238000012790 confirmation Methods 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
230000007812 deficiency Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
238000000432 density-gradient centrifugation Methods 0.000 description 2
239000005547 deoxyribonucleotide Substances 0.000 description 2
238000013461 design Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000003599 detergent Substances 0.000 description 2
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
229960003957 dexamethasone Drugs 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
239000002612 dispersion medium Substances 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
239000006196 drop Substances 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
238000010828 elution Methods 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
229940105423 erythropoietin Drugs 0.000 description 2
238000005558 fluorometry Methods 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
238000003306 harvesting Methods 0.000 description 2
210000003128 head Anatomy 0.000 description 2
208000009429 hemophilia B Diseases 0.000 description 2
230000002440 hepatic effect Effects 0.000 description 2
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
238000003384 imaging method Methods 0.000 description 2
230000028993 immune response Effects 0.000 description 2
238000003125 immunofluorescent labeling Methods 0.000 description 2
238000010874 in vitro model Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000002054 inoculum Substances 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
238000010255 intramuscular injection Methods 0.000 description 2
239000007927 intramuscular injection Substances 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
239000012139 lysis buffer Substances 0.000 description 2
235000019359 magnesium stearate Nutrition 0.000 description 2
239000004530 micro-emulsion Substances 0.000 description 2
235000019813 microcrystalline cellulose Nutrition 0.000 description 2
239000008108 microcrystalline cellulose Substances 0.000 description 2
229940016286 microcrystalline cellulose Drugs 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000000663 muscle cell Anatomy 0.000 description 2
239000007923 nasal drop Substances 0.000 description 2
229940100662 nasal drops Drugs 0.000 description 2
239000013642 negative control Substances 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
239000002674 ointment Substances 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
239000006072 paste Substances 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920000193 polymethacrylate Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
239000004814 polyurethane Substances 0.000 description 2
229920002635 polyurethane Polymers 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
239000003380 propellant Substances 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011002 quantification Methods 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
230000009919 sequestration Effects 0.000 description 2
238000013207 serial dilution Methods 0.000 description 2
210000002027 skeletal muscle Anatomy 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
235000019333 sodium laurylsulphate Nutrition 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000003860 storage Methods 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
238000013268 sustained release Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
238000007910 systemic administration Methods 0.000 description 2
239000004408 titanium dioxide Substances 0.000 description 2
235000010215 titanium dioxide Nutrition 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
SENMPMXZMGNQAG-UHFFFAOYSA-N 3,4-dihydro-2,5-benzodioxocine-1,6-dione Chemical compound O=C1OCCOC(=O)C2=CC=CC=C12 SENMPMXZMGNQAG-UHFFFAOYSA-N 0.000 description 1
XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 description 1
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 1
GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
108010056962 Adenovirus E4 Proteins Proteins 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
241001167018 Aroa Species 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
108700003860 Bacterial Genes Proteins 0.000 description 1
208000034309 Bacterial disease carrier Diseases 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
108010087504 Beta-Globulins Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
239000004255 Butylated hydroxyanisole Substances 0.000 description 1
239000004322 Butylated hydroxytoluene Substances 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
108090000565 Capsid Proteins Proteins 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
108010036867 Cerebroside-Sulfatase Proteins 0.000 description 1
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
239000004709 Chlorinated polyethylene Substances 0.000 description 1
102100022641 Coagulation factor IX Human genes 0.000 description 1
102100033779 Collagen alpha-4(IV) chain Human genes 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
241000938605 Crocodylia Species 0.000 description 1
244000303965 Cyamopsis psoralioides Species 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
239000004338 Dichlorodifluoromethane Substances 0.000 description 1
101100465553 Dictyostelium discoideum psmB6 gene Proteins 0.000 description 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
101100438426 Drosophila melanogaster Art4 gene Proteins 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
241000702224 Enterobacteria phage M13 Species 0.000 description 1
241000283086 Equidae Species 0.000 description 1
102100031939 Erythropoietin Human genes 0.000 description 1
101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 1
241000702189 Escherichia virus Mu Species 0.000 description 1
241000702191 Escherichia virus P1 Species 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
206010016077 Factor IX deficiency Diseases 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
101100321669 Fagopyrum esculentum FA02 gene Proteins 0.000 description 1
102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 1
239000004606 Fillers/Extenders Substances 0.000 description 1
241000233866 Fungi Species 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
108010014458 Gin recombinase Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108010017544 Glucosylceramidase Proteins 0.000 description 1
108010060309 Glucuronidase Proteins 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
229920002971 Heparan sulfate Polymers 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
208000011683 Hereditary muscle disease Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000710870 Homo sapiens Collagen alpha-4(IV) chain Proteins 0.000 description 1
101000783960 Homo sapiens N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase Proteins 0.000 description 1
101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
208000032420 Latent Infection Diseases 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
108091027974 Mature messenger RNA Proteins 0.000 description 1
201000011442 Metachromatic leukodystrophy Diseases 0.000 description 1
101000742280 Milk vetch dwarf virus (isolate N) Para-Rep C10 Proteins 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
241001529936 Murinae Species 0.000 description 1
208000021642 Muscular disease Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
208000008636 Neoplastic Processes Diseases 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
208000025966 Neurological disease Diseases 0.000 description 1
108091092724 Noncoding DNA Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
101150101654 PSR1 gene Proteins 0.000 description 1
108091081548 Palindromic sequence Proteins 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
208000037273 Pathologic Processes Diseases 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
241000254064 Photinus pyralis Species 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229920002367 Polyisobutene Polymers 0.000 description 1
229920001328 Polyvinylidene chloride Polymers 0.000 description 1
102100035620 Protein phosphatase 1 regulatory subunit 12C Human genes 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
241001340896 Pyralis Species 0.000 description 1
101100169519 Pyrococcus abyssi (strain GE5 / Orsay) dapAL gene Proteins 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
101100463797 Rattus norvegicus Pgrmc1 gene Proteins 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
206010038997 Retroviral infections Diseases 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
241000724205 Rice stripe tenuivirus Species 0.000 description 1
244000000231 Sesamum indicum Species 0.000 description 1
206010040880 Skin irritation Diseases 0.000 description 1
239000004141 Sodium laurylsulphate Substances 0.000 description 1
241000282887 Suidae Species 0.000 description 1
239000008051 TBE buffer Substances 0.000 description 1
BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
208000002903 Thalassemia Diseases 0.000 description 1
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
229920002433 Vinyl chloride-vinyl acetate copolymer Polymers 0.000 description 1
239000003070 absorption delaying agent Substances 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
210000005058 airway cell Anatomy 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
229940087168 alpha tocopherol Drugs 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
150000001413 amino acids Chemical group 0.000 description 1
239000003708 ampul Substances 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
239000003429 antifungal agent Substances 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000008135 aqueous vehicle Substances 0.000 description 1
101150037081 aroA gene Proteins 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
230000003190 augmentative effect Effects 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
ZPOLOEWJWXZUSP-WAYWQWQTSA-N bis(prop-2-enyl) (z)-but-2-enedioate Chemical compound C=CCOC(=O)\C=C/C(=O)OCC=C ZPOLOEWJWXZUSP-WAYWQWQTSA-N 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
229940124630 bronchodilator Drugs 0.000 description 1
239000000168 bronchodilator agent Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
229920005549 butyl rubber Polymers 0.000 description 1
235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
229940043253 butylated hydroxyanisole Drugs 0.000 description 1
CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
229940095259 butylated hydroxytoluene Drugs 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
238000012219 cassette mutagenesis Methods 0.000 description 1
230000007248 cellular mechanism Effects 0.000 description 1
229960000541 cetyl alcohol Drugs 0.000 description 1
229940112822 chewing gum Drugs 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
230000002995 comedolytic effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
101150011371 dapA gene Proteins 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
230000032798 delamination Effects 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
229960003964 deoxycholic acid Drugs 0.000 description 1
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
238000010586 diagram Methods 0.000 description 1
GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
229940042935 dichlorodifluoromethane Drugs 0.000 description 1
229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
239000004205 dimethyl polysiloxane Substances 0.000 description 1
208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
239000000975 dye Substances 0.000 description 1
238000004043 dyeing Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
229920005558 epichlorohydrin rubber Polymers 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
239000011536 extraction buffer Substances 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000002073 fluorescence micrograph Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000006260 foam Substances 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
239000003205 fragrance Substances 0.000 description 1
238000002825 functional assay Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
108010074605 gamma-Globulins Proteins 0.000 description 1
239000007789 gas Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
238000007429 general method Methods 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
239000008187 granular material Substances 0.000 description 1
238000000227 grinding Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
208000014951 hematologic disease Diseases 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
230000002363 herbicidal effect Effects 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
229920001903 high density polyethylene Polymers 0.000 description 1
239000004700 high-density polyethylene Substances 0.000 description 1
239000003906 humectant Substances 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
239000005414 inactive ingredient Substances 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
229940060367 inert ingredients Drugs 0.000 description 1
238000013383 initial experiment Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
230000000266 injurious effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
239000000644 isotonic solution Substances 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000003410 keratolytic agent Substances 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
239000008101 lactose Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
244000144972 livestock Species 0.000 description 1
229920001684 low density polyethylene Polymers 0.000 description 1
239000004702 low-density polyethylene Substances 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
210000005265 lung cell Anatomy 0.000 description 1
238000002803 maceration Methods 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
239000000395 magnesium oxide Substances 0.000 description 1
CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000000155 melt Substances 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
229940071648 metered dose inhaler Drugs 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
238000007479 molecular analysis Methods 0.000 description 1
229910052901 montmorillonite Inorganic materials 0.000 description 1
239000004570 mortar (masonry) Substances 0.000 description 1
238000000465 moulding Methods 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
229940051866 mouthwash Drugs 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
AEMBWNDIEFEPTH-UHFFFAOYSA-N n-tert-butyl-n-ethylnitrous amide Chemical compound CCN(N=O)C(C)(C)C AEMBWNDIEFEPTH-UHFFFAOYSA-N 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
239000006199 nebulizer Substances 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000012457 nonaqueous media Substances 0.000 description 1
230000030648 nucleus localization Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
238000005457 optimization Methods 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
210000003695 paranasal sinus Anatomy 0.000 description 1
239000013618 particulate matter Substances 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
230000002572 peristaltic effect Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
238000007747 plating Methods 0.000 description 1
229920001084 poly(chloroprene) Polymers 0.000 description 1
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
229920000151 polyglycol Polymers 0.000 description 1
239000010695 polyglycol Substances 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
239000005033 polyvinylidene chloride Substances 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
238000011176 pooling Methods 0.000 description 1
229910052573 porcelain Inorganic materials 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 1
QTECDUFMBMSHKR-UHFFFAOYSA-N prop-2-enyl prop-2-enoate Chemical compound C=CCOC(=O)C=C QTECDUFMBMSHKR-UHFFFAOYSA-N 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
ULBKMFLWMIGVOJ-CFXUUZMDSA-M propicillin potassium Chemical compound [K+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C(CC)OC1=CC=CC=C1 ULBKMFLWMIGVOJ-CFXUUZMDSA-M 0.000 description 1
150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
238000009790 rate-determining step (RDS) Methods 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
101150066583 rep gene Proteins 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
238000003757 reverse transcription PCR Methods 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000011451 sequencing strategy Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
150000003376 silicon Chemical class 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000012239 silicon dioxide Nutrition 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
210000000162 simple eye Anatomy 0.000 description 1
230000036556 skin irritation Effects 0.000 description 1
231100000475 skin irritation Toxicity 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
239000000344 soap Substances 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
235000010199 sorbic acid Nutrition 0.000 description 1
239000004334 sorbic acid Substances 0.000 description 1
229940075582 sorbic acid Drugs 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
229920003002 synthetic resin Polymers 0.000 description 1
239000000057 synthetic resin Substances 0.000 description 1
238000010257 thawing Methods 0.000 description 1
230000008719 thickening Effects 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
229960000984 tocofersolan Drugs 0.000 description 1
239000012049 topical pharmaceutical composition Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000013271 transdermal drug delivery Methods 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
108091008578 transmembrane receptors Proteins 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
229940029284 trichlorofluoromethane Drugs 0.000 description 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
230000004095 viral genome expression Effects 0.000 description 1
230000010464 virion assembly Effects 0.000 description 1
239000000277 virosome Substances 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000001993 wax Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
239000002076 α-tocopherol Substances 0.000 description 1
235000004835 α-tocopherol Nutrition 0.000 description 1